Among these was a study that looked at whether it was possible for the drug lenacapavir to protect against acquiring HIV for a whole year. Last year, results from the pivotal phase three studies ...

The drug was safe, too (it’s already approved to treat HIV infections). And it only needed to be injected twice a year to offer full protection. This week, the results of a small phase I trial ...

The President of the Ghana HIV/AIDS Network ... urging young people to embrace a culture of protection during sexual intercourse. Here are five things he highlighted: Ensure that you wear a ...

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops the ...

A yearly injection to protect against HIV is safe and shows promise as a prevention method with long-lasting effects, according to the results of a clinical trial published in The Lancet journal.

He cautioned citizens to use condoms the proper way to protect themselves from getting infected with HIV and to check for the expiration dates on the products before using them. Ortsin stressed ...